Investors

Stock
Information

MEDINCELL EURONEXT ELIGIBLE PME PEA

Listed on
EURONEXT PARIS / B COMPARTMENT
ISIN code / Ticker
FR0004065605 / MEDCL
Number of shares (May 31, 2022)
25,143,553
Liquidity Provider
KEPLER CHEUVREUX
Analysts
BRYAN GARNIER & CO
KEPLER CHEUVREUX
ODDO-BHF

Download our latest corporate presentation

Share price 03.10.2022 | 12:51 (Paris time)
5.43 €1.12%
Opening5.46 €
Previous closing 5.37 €
Shares traded 3.23 k
Chart by Visualizer

Investors

Events &
Presentations

June 14, 2022

MedinCell
Annual results 2021-2022 (Apr. 2021 > Mar. 2022)

September 08, 2022

MedinCell
2022 General Meeting

December 06, 2022

MedinCell
Half-Year results
(Apr. > Sept. 2022)

PREVIOUS EVENTS

September 08, 2022

General Meeting (French)

Replay

September 05, 2022

Videoconference • General meeting preparation (French)

Replay

June 14, 2022

Videoconference • Annual results 2021-202

Replay

Transcript Presentation

December 08, 2021

Videoconference • Half Year results

Replay

Transcript Presentation

November 02, 2021

Videoconference • mdc-IRM Phase 3 results

Replay

Transcript

September 01, 2021

Video conference • Portfolio update

Replay

Transcript Presentation

June 16, 2021

Video Conference • Annual results

Replay

Transcript Presentation

December 09, 2020

Video Conference • Half year results

Replay

Transcript

June 04, 2020

Video Conference • Annual results

Replay

Transcript

April 23, 2020

Video Conference • Adapt and overcome to the Covid-19 crisis

Replay

Transcript Presentation

December 03, 2019

Audio conference • Half year results

Replay

Transcript Presentation

June 04, 2019

Audio Conference • Annual results

Replay

Transcript Presentation

December 03, 2018

Audio Conference • Half year results

Replay

Transcript Presentation

Session en français

Rendez-vous le lundi 5 septembre à 18h30 (CEST) pour une vidéoconférence dédiée à la présentation des résolution de l'Assemblée Générale

English session

On Monday 5, September at 6.30 pm (CEST) participate in our videoconference dedicated to the presentation of the resolutions of the General meeting

INVESTORS

Êtes-vous un actionnaire de MedinCell ? / Are you a MedinCell shareholder?
Vous êtes / You are :
This field is for validation purposes and should be left unchanged.

Investors

Documentation

Investors

General
Meeting

September 2022
September 2021
September 2020
December 2020
September 2019

September 2022

Investors

Contacts

MedinCell

Head of Communication / IR

David Heuzé

david.heuze@medincell.com

+33 (0)6 83 25 21 86

MedinCell

Senior Communications Officer

Nicolas Gourgues

nicolas.gourgues@medincell.com

Investor Relations

NewCap

Louis-Victor Delouvrier & Mathilde Bohin

medincell@newcap.eu

+33 (0)1 44 71 94 94

Media

NewCap

Nicolas Merigeau

medincell@newcap.eu

+33 (0)1 44 71 94 94

CONTACT

  • This field is for validation purposes and should be left unchanged.